1,960
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2

, , ORCID Icon, & ORCID Icon
Pages 6097-6113 | Received 09 Jun 2020, Accepted 11 Jan 2021, Published online: 29 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kiarash Saleki, Mohamad Hosein Mohamadi, Parsa Alijanizadeh & Nima Rezaei. (2023) Neurological adverse effects of chimeric antigen receptor T-cell therapy. Expert Review of Clinical Immunology 19:11, pages 1361-1383.
Read now
Daniel Mekonnen, Hylemariam Mihiretie Mengist & Tengchuan Jin. (2022) SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways. Expert Review of Vaccines 21:1, pages 69-81.
Read now

Articles from other publishers (4)

Nima Javanmehr, Kiarash Saleki, Parsa Alijanizadeh & Nima Rezaei. (2022) Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases. Journal of Neuroinflammation 19:1.
Crossref
Nino Rcheulishvili, Dimitri Papukashvili, Cong Liu, Yang Ji, Yunjiao He & Peng George Wang. (2022) Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs– focus on the bigger picture. Frontiers in Immunology 13.
Crossref
Svetlana V. Guryanova & Tatiana V. Ovchinnikova. (2022) Immunomodulatory and Allergenic Properties of Antimicrobial Peptides. International Journal of Molecular Sciences 23:5, pages 2499.
Crossref
Kiarash Saleki, Moein Shirzad, Mohammad Banazadeh, Mohamad Hosein Mohamadi, Parsa Alijanizadeh, Nima Javanmehr, Ramtin Pourahmad, Mahdi Shakeri, Reza Nikkhoo Amiri, Payam Payandeh & Payam Saadat. 2022. Systemic Lupus Erythematosus - Pathogenesis and Management [Working Title]. Systemic Lupus Erythematosus - Pathogenesis and Management [Working Title].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.